{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T05:17:25Z","timestamp":1788153445705,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-026-02431-6","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:25:31Z","timestamp":1788150331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-market individual-report phenotypes after pulsed-field ablation for atrial fibrillation in a food and drug administration database"],"prefix":"10.1007","author":[{"given":"Joyce","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Man","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Yow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4641-745X","authenticated-orcid":false,"given":"Samuel","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"issue":"18","key":"2431_CR1","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1056\/NEJMoa2307291","volume":"389","author":"VY Reddy","year":"2023","unstructured":"Reddy VY, Gerstenfeld EP, Natale A, et al. ADVENT Investigators. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med. 2023;389(18):1660\u201371. https:\/\/doi.org\/10.1056\/NEJMoa2307291.","journal-title":"N Engl J Med"},{"key":"2431_CR2","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1038\/s41591-024-03114-3","volume":"30","author":"E Ekanem","year":"2024","unstructured":"Ekanem E, Neuzil P, Reichlin T, et al. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study. Nat Med. 2024;30:2020\u20139. https:\/\/doi.org\/10.1038\/s41591-024-03114-3.","journal-title":"Nat Med"},{"issue":"2","key":"2431_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jacc.2025.10.051","volume":"87","author":"MK Turagam","year":"2026","unstructured":"Turagam MK, Neuzil P, Schmidt B, et al. MANIFEST-US Investigators. Multicenter study on the safety of pulsed field ablation in over 40,000 patients: MANIFEST-US. J Am Coll Cardiol. 2026;87(2):172\u201393. https:\/\/doi.org\/10.1016\/j.jacc.2025.10.051.","journal-title":"J Am Coll Cardiol"},{"key":"2431_CR4","unstructured":"Food US, Administration D. Ablation catheter correction: Biosense Webster updates use instructions for Varipulse due to high rate of stroke or transient ischemic attack. 2025. Accessed 24 May 2026. https:\/\/www.fda.gov\/medical-devices\/medical-device-recalls-and-early-alerts\/ablation-catheter-correction-biosense-webster-updates-use-instructions-varipulse-due-high-rate."},{"issue":"19","key":"2431_CR5","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1161\/CIRCULATIONAHA.123.063988","volume":"147","author":"A Verma","year":"2023","unstructured":"Verma A, Haines DE, Boersma LV, et al. PULSED AF Investigators. Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation. 2023;147(19):1422\u201332. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.063988.","journal-title":"Circulation"},{"issue":"15","key":"2431_CR6","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1161\/CIRCULATIONAHA.124.070333","volume":"150","author":"VY Reddy","year":"2024","unstructured":"Reddy VY, Calkins H, Mansour M, et al. admIRE Trial Investigators. Pulsed field ablation to treat paroxysmal atrial fibrillation: safety and effectiveness in the admIRE pivotal trial. Circulation. 2024;150(15):1174\u201386. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.070333.","journal-title":"Circulation"},{"issue":"10","key":"2431_CR7","doi-asserted-by":"publisher","first-page":"euae251","DOI":"10.1093\/europace\/euae251","volume":"26","author":"MAJ De Smet","year":"2024","unstructured":"De Smet MAJ, De Cocker J, Huybrechts W, et al. Intravascular haemolysis and acute kidney injury following atrial fibrillation ablation: a report using two different systems for pulsed field ablation. Europace. 2024;26(10):euae251. https:\/\/doi.org\/10.1093\/europace\/euae251.","journal-title":"Europace"},{"key":"2431_CR8","doi-asserted-by":"publisher","unstructured":"Martinez J, Challapalli M, Hutchinson M et al. Renal safety of high-dose pulsed field ablation of atrial fibrillation: a prospective real-world analysis. Heart Rhythm. 2025. https:\/\/doi.org\/10.1016\/j.hrthm.2025.07.026.","DOI":"10.1016\/j.hrthm.2025.07.026"},{"issue":"6","key":"2431_CR9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s10840-024-01935-3","volume":"68","author":"P Futela","year":"2025","unstructured":"Futela P, Kowlgi GN, DeSimone CV, et al. Early insights on adverse events associated with PulseSelect and FARAPULSE: analysis of the MAUDE database. J Interv Card Electrophysiol. 2025;68(6):1359\u201361. https:\/\/doi.org\/10.1007\/s10840-024-01935-3.","journal-title":"J Interv Card Electrophysiol"},{"issue":"9","key":"2431_CR10","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.hrthm.2024.10.063","volume":"22","author":"MS Cho","year":"2025","unstructured":"Cho MS, Lee SR, Black-Maier E, et al. Complications associated with pulsed field ablation vs radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm. 2025;22(9):2194\u2013200. https:\/\/doi.org\/10.1016\/j.hrthm.2024.10.063.","journal-title":"Heart Rhythm"},{"key":"2431_CR11","unstructured":"U.S. Food and Drug Administration. About Manufacturer and User Facility Device Experience (MAUDE) database. 2025. Accessed 24 May 2026. https:\/\/www.fda.gov\/medical-devices\/mandatory-reporting-requirements-manufacturers-importers-and-device-user-facilities\/about-manufacturer-and-user-facility-device-experience-maude-database."},{"key":"2431_CR12","unstructured":"U.S. Food and Drug Administration. MDR adverse event codes. 2026. Accessed 24 May 2026. https:\/\/www.fda.gov\/medical-devices\/mandatory-reporting-requirements-manufacturers-importers-and-device-user-facilities\/mdr-adverse-event-codes."},{"issue":"1","key":"2431_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clinthera.2024.10.004","volume":"47","author":"M Mishali","year":"2025","unstructured":"Mishali M, Sheffer N, Mishali O, Negev M. Understanding variation among medical device reporting sources: a study of the MAUDE database. Clin Ther. 2025;47(1):76\u201381. https:\/\/doi.org\/10.1016\/j.clinthera.2024.10.004.","journal-title":"Clin Ther"},{"issue":"9","key":"2431_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jacc.2022.11.060","volume":"81","author":"JC Hsu","year":"2023","unstructured":"Hsu JC, Calkins H, Spertus JA, et al. Initial findings from the National Cardiovascular Data Registry of atrial fibrillation ablation procedures. J Am Coll Cardiol. 2023;81(9):867\u201378. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.060.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"2431_CR15","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.jacc.2023.03.418","volume":"81","author":"K Benali","year":"2023","unstructured":"Benali K, Khairy P, Hammache N, et al. Procedure-related complications of catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2023;81(21):2089\u201399. https:\/\/doi.org\/10.1016\/j.jacc.2023.03.418.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"2431_CR16","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/CIRCULATIONAHA.122.061497","volume":"146","author":"VY Reddy","year":"2022","unstructured":"Reddy VY, Petru J, Funasako M, et al. Coronary arterial spasm during pulsed field ablation to treat atrial fibrillation. Circulation. 2022;146(24):1808\u201319. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.061497.","journal-title":"Circulation"},{"issue":"1","key":"2431_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/jamacardio.2023.4405","volume":"9","author":"C Zhang","year":"2024","unstructured":"Zhang C, Neuzil P, Petru J, et al. Coronary artery spasm during pulsed field vs radiofrequency catheter ablation of the mitral isthmus. JAMA Cardiol. 2024;9(1):72\u20137. https:\/\/doi.org\/10.1001\/jamacardio.2023.4405.","journal-title":"JAMA Cardiol"},{"issue":"5","key":"2431_CR18","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s10840-023-01720-8","volume":"67","author":"B De Becker","year":"2024","unstructured":"De Becker B, Francois C, De Smet M, et al. Severe coronary spasm occurring remotely from pulsed field application during right inferior pulmonary vein isolation. J Interv Card Electrophysiol. 2024;67(5):1075\u20136. https:\/\/doi.org\/10.1007\/s10840-023-01720-8.","journal-title":"J Interv Card Electrophysiol"},{"issue":"6","key":"2431_CR19","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/ejh.70155","volume":"116","author":"Oral Anticoagulation After Atrial Fibrillation Ablation","year":"2026","unstructured":"Oral Anticoagulation After Atrial Fibrillation Ablation. An Updated Systematic Review and Meta-Analysis of 267,443 Patients. Eur J Haematol. 2026;116(6):915\u201327. https:\/\/doi.org\/10.1111\/ejh.70155.","journal-title":"Eur J Haematol"},{"issue":"8","key":"2431_CR20","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.3390\/jcm14082741","volume":"14","author":"Impact of Ablation Energy Sources on Perceived Quality of Life and Symptom in Atrial Fibrillation Patients","year":"2025","unstructured":"Impact of Ablation Energy Sources on Perceived Quality of Life and Symptom in Atrial Fibrillation Patients. A Comparative Study. J Clin Med. 2025;14(8):2741. https:\/\/doi.org\/10.3390\/jcm14082741.","journal-title":"J Clin Med"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02431-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02431-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02431-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:25:33Z","timestamp":1788150333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-026-02431-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":20,"alternative-id":["2431"],"URL":"https:\/\/doi.org\/10.1007\/s10840-026-02431-6","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"9 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used publicly available, deidentified FDA MAUDE data and did not require institutional review board approval.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}